Johanna Keeler's Talk on Psychedelic Treatments for ED's
Anorexia nervosa (AN) has the highest mortality rate of any psychiatric disorder, and a third of patients develop a chronic course of the illness. Current treatments show limited efficacy in improving symptoms, and there are no licensed pharmacological treatments for AN. Johanna Keeler, co-founder of the Exeter Eating Difficulties Peer Support Group, is a PhD student at the Section of Eating Disorders at King’s College London, and is exploring neurobiological factors that may contribute to the treatment-resistant state of AN. Hannah Douglass is a PhD student at Imperial College London exploring the use of psilocybin-assisted therapy as a treatment for AN. In this talk, Johanna and Hannah will explore potential neurobiological factors contributing to the maintenance of AN, before discussing patients’ views towards psychedelic research and planned trials of ketamine and psilocybin for the treatment of AN.